AU4640985A - Benzimidazole derivatives - Google Patents

Benzimidazole derivatives

Info

Publication number
AU4640985A
AU4640985A AU46409/85A AU4640985A AU4640985A AU 4640985 A AU4640985 A AU 4640985A AU 46409/85 A AU46409/85 A AU 46409/85A AU 4640985 A AU4640985 A AU 4640985A AU 4640985 A AU4640985 A AU 4640985A
Authority
AU
Australia
Prior art keywords
benzimidazole derivatives
benzimidazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46409/85A
Inventor
Masatoshi Hayashi
Yutaka Nomura
Susumu Okabe
Masaru Satoh
Tomio Yamakawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Chemiphar Co Ltd
Original Assignee
Nippon Chemiphar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP59182400A external-priority patent/JPS6160660A/en
Priority claimed from JP60061195A external-priority patent/JPH0764826B2/en
Priority claimed from JP60061194A external-priority patent/JPH068283B2/en
Application filed by Nippon Chemiphar Co Ltd filed Critical Nippon Chemiphar Co Ltd
Publication of AU4640985A publication Critical patent/AU4640985A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU46409/85A 1984-08-31 1985-08-19 Benzimidazole derivatives Abandoned AU4640985A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP59-182400 1984-08-31
JP59182400A JPS6160660A (en) 1984-08-31 1984-08-31 Benzimidazole derivative, its preparation, and antitumor agent containing it
JP60-61194 1985-03-26
JP60061195A JPH0764826B2 (en) 1985-03-26 1985-03-26 Benzimidazole derivative
JP60061194A JPH068283B2 (en) 1985-03-26 1985-03-26 Benzimidazole derivative, method for producing the same, and antiulcer agent containing the same
JP60-61195 1985-03-26

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU41271/89A Division AU4127189A (en) 1984-08-31 1989-09-11 Benzimidazole derivatives, process for preparing the same and antiulcer agents containing the same

Publications (1)

Publication Number Publication Date
AU4640985A true AU4640985A (en) 1986-03-06

Family

ID=27297422

Family Applications (3)

Application Number Title Priority Date Filing Date
AU46409/85A Abandoned AU4640985A (en) 1984-08-31 1985-08-19 Benzimidazole derivatives
AU41271/89A Abandoned AU4127189A (en) 1984-08-31 1989-09-11 Benzimidazole derivatives, process for preparing the same and antiulcer agents containing the same
AU29750/92A Ceased AU647978B2 (en) 1984-08-31 1992-11-27 Benzimidazole derivatives

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU41271/89A Abandoned AU4127189A (en) 1984-08-31 1989-09-11 Benzimidazole derivatives, process for preparing the same and antiulcer agents containing the same
AU29750/92A Ceased AU647978B2 (en) 1984-08-31 1992-11-27 Benzimidazole derivatives

Country Status (14)

Country Link
KR (1) KR920004936B1 (en)
AR (1) AR242195A1 (en)
AU (3) AU4640985A (en)
BE (1) BE903128A (en)
BR (1) BR8504252A (en)
CH (1) CH665417A5 (en)
DE (1) DE3531487C2 (en)
ES (1) ES8703142A1 (en)
FR (1) FR2569691B1 (en)
GB (1) GB2163747B (en)
IT (1) IT1189601B (en)
MX (1) MX159807A (en)
NL (1) NL8502384A (en)
SE (1) SE500669C2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU594074B2 (en) * 1985-08-14 1990-03-01 Nippon Chemiphar Co. Ltd. Cytoprotective agent for gastrointestinal tract
AU619444B2 (en) * 1986-06-02 1992-01-30 Nippon Chemiphar Co. Ltd. 2-(2-aminobenzylsulfinyl)- benzimidazole derivatives

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8417194D0 (en) * 1984-07-05 1984-08-08 Boots Co Plc Therapeutic agents
GB2161160B (en) * 1984-07-06 1989-05-24 Fisons Plc Heterocyclic sulphinyl compounds
EP0174717B1 (en) 1984-07-06 1992-01-22 FISONS plc Benzimidazoles, and their production formulation and use as gastric acid secretion inhibitors
US5869513A (en) * 1985-05-24 1999-02-09 G. D. Searle & Co. 2- (1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines
AU5768886A (en) * 1985-05-24 1986-11-27 G.D. Searle & Co. 2-((1-h-benzimidazol-2-ylsulfinyl)methyl)benzenamines
WO1987001114A2 (en) * 1985-08-21 1987-02-26 Byk Gulden Lomberg Chemische Fabrik Gmbh New amines, process for their manufacture, their use and medicines containing them
AR243167A1 (en) 1985-08-24 1993-07-30 Hoechst Ag Substituted toluidines, process for their preparation, pharmaceutical compositions containing them and their use as gastric secretion inhibitors
EP0251536A1 (en) * 1986-06-24 1988-01-07 FISONS plc Benzimidazoles, their production, formulation and use as gastric acid secretion inhibitors
US4772619A (en) * 1986-07-17 1988-09-20 G. D. Searle & Co. [(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines
US4687775A (en) * 1986-07-17 1987-08-18 G. D. Searle & Co. 2-[(Imidazo[1,2-a]pyridinylmethyl)sulfinyl]-1H-benzimidazoles
US4721718A (en) * 1986-08-18 1988-01-26 G. D. Searle & Co. 2-[(imidazo[1,2-a]pyridin-3-ylmethyl)sulfinyl]-1H-benzimidazoles useful in the treatment and prevention of ulcers
DE3639926A1 (en) * 1986-11-22 1988-06-01 Hoechst Ag SUBSTITUTED THIENOIMIDAZOLTOLUIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING IT AND THEIR USE AS AN INGESTIC ACID INHIBITOR
IT1222412B (en) * 1987-07-31 1990-09-05 Chiesi Farma Spa THYOMETHYL AND SULFINYL METHYL DERIVED WITH ANTI-SECRET ACID GASTRIC ACTION, THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
JP2614756B2 (en) * 1988-08-10 1997-05-28 日本ケミファ株式会社 Imidazole derivative, method for producing the same, and anti-ulcer agent containing the same
JPH06298611A (en) * 1993-04-16 1994-10-25 Nippon Chemiphar Co Ltd Antibacterial agent
SE9301489D0 (en) 1993-04-30 1993-04-30 Ab Astra VETERINARY COMPOSITION
SE9402431D0 (en) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
SE9500422D0 (en) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9500478D0 (en) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
HRP960232A2 (en) * 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds
ES2236628T3 (en) * 1995-09-21 2005-07-16 Pharma Pass Ii Llc PHARMACEUTICAL COMPOSITION CONTAINING A LABIL ACID OMEPRAZOL, AND PROCEDURE FOR PREPARATION.
SE9600070D0 (en) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
US6380222B2 (en) 1996-10-11 2002-04-30 Astrazeneca Ab Use of an H+, K+-atpase inhibitor in the treatment of nasal polyps
EP1003554B1 (en) 1997-07-25 2004-11-03 ALTANA Pharma AG Proton pump inhibitor in therapeutic combination with antibacterial substances
SE9704869D0 (en) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
SE9704870D0 (en) 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
JP4988088B2 (en) 1998-08-12 2012-08-01 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング Oral dosage form composition of pyridin-2-ylmethylsulfinyl-1H-benzimidazole, a compound having a skeleton of pyridin-2-ylmethylsulfinyl-1H-benzimidazole, or a pharmaceutically acceptable salt thereof is fixed. Composition combined with
WO2000027841A1 (en) * 1998-11-06 2000-05-18 Dong-A Pharmaceutical Co., Ltd. Method of preparing sulfide derivatives
TWI243672B (en) 1999-06-01 2005-11-21 Astrazeneca Ab New use of compounds as antibacterial agents
HUP0201637A3 (en) 1999-06-07 2004-05-28 Altana Pharma Ag Novel preparation and administration form comprising an acid-labile active compound
SE9903831D0 (en) 1999-10-22 1999-10-22 Astra Ab Formulation of substituted benzimidazoles
SE0000774D0 (en) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
US6544556B1 (en) 2000-09-11 2003-04-08 Andrx Corporation Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
SE0101379D0 (en) 2001-04-18 2001-04-18 Diabact Ab Composition that inhibits gastric acid secretion
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
SE0102993D0 (en) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
WO2003084518A2 (en) 2002-04-09 2003-10-16 Flamel Technologies Oral suspension of active principle microcapsules
ATE407674T1 (en) 2002-04-09 2008-09-15 Flamel Tech Sa ORAL PHARMACEUTICAL FORMULATION IN THE FORM OF AN AQUEOUS SUSPENSION OF MICROCAPSULES FOR THE MODIFIED RELEASE OF AMOXICILLIN
SE0203065D0 (en) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
CA2529984C (en) 2003-06-26 2012-09-25 Isa Odidi Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
CA2540308C (en) 2003-09-26 2013-08-06 Alza Corporation Drug coating providing high drug loading and methods for providing the same
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
EP2007360B1 (en) 2006-04-03 2014-11-26 Isa Odidi Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
PL2046334T3 (en) 2006-07-25 2015-02-27 Vecta Ltd Compositions and meth0ds for inhibiting gastric acide secretion using derivatives of small dicarboxylic acids in combination with ppi
RU2491075C2 (en) 2006-12-22 2013-08-27 Айронвуд Фармасьютикалз, Инк. Methods and compositions for treating oesophageal disorders
AU2009290712A1 (en) 2008-09-09 2010-03-18 Astrazeneca Ab Method for delivering a pharmaceutical composition to patient in need thereof
CA2764963C (en) 2009-06-25 2016-11-01 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
WO2011080500A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080502A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080501A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
EP2601947A1 (en) 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Fixed-dose combination for treatment of helicobacter pylori associated diseases
CA2860231A1 (en) 2011-12-28 2013-07-04 Pozen Inc. Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
US20160015644A1 (en) 2013-01-15 2016-01-21 Ironwood Pharmaceuticals, Inc. Gastro-retentive sustained-release oral dosage form of a bile acid sequestrant
EP2801565B1 (en) * 2013-05-06 2015-07-22 King Saud University Compounds for use as anti-ulcer agent and/or anti-Helicobacter pylori agent and pharmaceutical compositions thereof
WO2016126625A1 (en) 2015-02-03 2016-08-11 Ironwood Pharmaceuticals, Inc. Methods of treating upper gastrointestinal disorders in ppi refractory gerd

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
EP0174717B1 (en) * 1984-07-06 1992-01-22 FISONS plc Benzimidazoles, and their production formulation and use as gastric acid secretion inhibitors

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU594074B2 (en) * 1985-08-14 1990-03-01 Nippon Chemiphar Co. Ltd. Cytoprotective agent for gastrointestinal tract
AU619444B2 (en) * 1986-06-02 1992-01-30 Nippon Chemiphar Co. Ltd. 2-(2-aminobenzylsulfinyl)- benzimidazole derivatives

Also Published As

Publication number Publication date
KR920004936B1 (en) 1992-06-22
BE903128A (en) 1985-12-16
AU4127189A (en) 1989-12-21
AU2975092A (en) 1993-01-28
IT8567743A0 (en) 1985-08-30
SE8504048D0 (en) 1985-08-30
MX159807A (en) 1989-08-31
AU647978B2 (en) 1994-03-31
NL8502384A (en) 1986-03-17
ES546445A0 (en) 1986-11-16
DE3531487A1 (en) 1986-03-13
BR8504252A (en) 1986-06-17
GB2163747A (en) 1986-03-05
SE500669C2 (en) 1994-08-08
FR2569691B1 (en) 1989-08-04
FR2569691A1 (en) 1986-03-07
GB8521493D0 (en) 1985-10-02
ES8703142A1 (en) 1986-11-16
CH665417A5 (en) 1988-05-13
DE3531487C2 (en) 1995-08-17
AR242195A1 (en) 1993-03-31
SE8504048L (en) 1986-03-01
GB2163747B (en) 1989-02-08
KR860001793A (en) 1986-03-22
IT1189601B (en) 1988-02-04

Similar Documents

Publication Publication Date Title
AU570130B2 (en) 2-pyridylmethylthio-and 2-pyridylmethylsulfinyl benzimidazole derivatives
AU2975092A (en) Benzimidazole derivatives
AU1117788A (en) Benzoxazone derivatives
AU4325485A (en) Aminoalkylphenoxy derivatives
AU4263685A (en) Ammotetralin derivatives
AU568441B2 (en) 2-(pyridylalkenesulfinyl) benzimidazole derivatives
AU5123285A (en) 2-piperizino-pteridine derivatives
AU572850B2 (en) Benzimidazole derivatives
AU582894B2 (en) Benzimidazole derivatives
AU576634B2 (en) Benzimidazole derivatives
AU5131685A (en) Aminoacyllabdane derivatives
AU4738185A (en) Carbamoylimidazole derivatives
AU4086885A (en) Hydroxy-4-2h-1-benzothiopyran-2-one derivatives
AU4343885A (en) Indole - tetrahydropyridyl derivatives
AU3797485A (en) Azolyl-aryl-alkanol derivatives
AU4145285A (en) Tetrahydroquinolin-1-yl- carbonylimidazole derivatives
AU4168885A (en) Chartreusin derivatives
AU4005885A (en) 2-oxindole-1-carboxamide derivatives
AU589555B2 (en) Imidazole derivatives
AU4901285A (en) 2 - cyanobenzimidazole derivatives
AU4106085A (en) 2 - oxoindole derivatives
ZA856187B (en) Benzimidazole derivatives
AU4045585A (en) Sulphamoylguanidine derivatives
AU3977285A (en) Carboxyalkyldipeptide derivatives
AU4083185A (en) Eburnane derivatives